‌

US Patent 10959948 Composition and method for vancomycin oral liquid

Patent 10959948 was granted and assigned to Azurity Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Azurity Pharmaceuticals

0

Current Assignee

Azurity Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Peter Mione0

Anisa Gandhi0

Cristina LeChiara0

Indu Muni0

Date of Patent

March 30, 2021

0

Patent Application Number

169414000

Date Filed

July 28, 2020

0

Patent Citations

US Patent 10493028 Composition and method for vancomycin oral liquid

US Patent 10688046 Composition and method for vancomycin oral liquid

Patent Citations Received

US Patent 11638692 Composition and method for vancomycin oral liquid

0

Patent Primary Examiner

0

Patent abstract

The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10959948 Composition and method for vancomycin oral liquid

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.